Cerebral Cavernous Malformation
Welcome,         Profile    Billing    Logout  
 1 Company   1 Product   1 Product   1 Mechanism of Action   0 Trials   3 News 
  • ||||||||||  simvastatin / Generic mfg.
    Trial termination:  Permeability MRI in Cerebral Cavernous Malformations Type 1 in New Mexico: Effects of Statins (clinicaltrials.gov) -  Mar 12, 2024   
    P1,  N=12, Terminated, 
    Completed --> Terminated; Research was completed before January 18, 2017, & does not meet the Applicable Clinical Trial requirement to register & report results per the guidance provided in "Clinical Trials Registration & Results Information Submission" dated 09/21/2016.
  • ||||||||||  simvastatin / Generic mfg.
    Trial completion, Enrollment change, Trial primary completion date:  Permeability MRI in Cerebral Cavernous Malformations Type 1 in New Mexico: Effects of Statins (clinicaltrials.gov) -  Apr 11, 2016   
    P0,  N=12, Completed, 
    Completed --> Terminated; Research was completed before January 18, 2017, & does not meet the Applicable Clinical Trial requirement to register & report results per the guidance provided in "Clinical Trials Registration & Results Information Submission" dated 09/21/2016. Recruiting --> Completed | N=30 --> 12 | Trial primary completion date: Jun 2019 --> Jan 2016